Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1986 Nov;49(11):1251–1257. doi: 10.1136/jnnp.49.11.1251

A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy.

P Crawford, D Chadwick
PMCID: PMC1029073  PMID: 3098923

Abstract

A three way single blind cross-over comparison of progabide, valproate and placebo, as adjunctive therapy, was undertaken in 64 patients with therapy-resistant partial and generalised seizures. The study was not completed because of the incidence of elevated hepatic enzymes on progabide. Analysis of efficacy showed progabide to be inferior to valproate against all seizure types, particularly against tonic-clonic seizures. Valproate was superior to placebo against all seizure types, partial and tonic-clonic seizures. Progabide did not differ significantly from placebo in any instance. In addition progabide caused elevation of hepatic enzymes which was symptomatic in one case, and was associated with an interaction with phenytoin which resulted in symptoms of intoxication in some cases.

Full text

PDF
1251

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chadwick D., Turnbull D. M. The comparative efficacy of antiepileptic drugs for partial and tonic-clonic seizures. J Neurol Neurosurg Psychiatry. 1985 Nov;48(11):1073–1077. doi: 10.1136/jnnp.48.11.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Loiseau P., Bossi L., Guyot M., Orofiamma B., Morselli P. L. Double-blind crossover trial of progabide versus placebo in severe epilepsies. Epilepsia. 1983 Dec;24(6):703–715. doi: 10.1111/j.1528-1157.1983.tb04633.x. [DOI] [PubMed] [Google Scholar]
  3. Martínez-Lage J. M., Bossi L., Morales G., Martínez Vila E., Orofiamma B., Viteri C. Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo. Epilepsia. 1984 Oct;25(5):586–593. doi: 10.1111/j.1528-1157.1984.tb03466.x. [DOI] [PubMed] [Google Scholar]
  4. Padovani P., Deves C., Bianchetti G., Thenot J. P., Morselli P. L. Determination of progabide and its main acid metabolite in biological fluids using high-performance liquid chromatography and electrochemical detection. Application to the measurement of blood/plasma partition ratio. J Chromatogr. 1984 Jun 8;308:229–239. doi: 10.1016/s0021-9673(01)87549-x. [DOI] [PubMed] [Google Scholar]
  5. Perchalski R. J., Scott K. N., Wilder B. J., Hammer R. H. Rapid, simultaneous GLC determination of phenobarbital, primidone, and diphenylhydantoin. J Pharm Sci. 1973 Oct;62(10):1735–1736. doi: 10.1002/jps.2600621042. [DOI] [PubMed] [Google Scholar]
  6. Turnbull D. M., Howel D., Rawlins M. D., Chadwick D. W. Which drug for the adult epileptic patient: phenytoin or valproate? Br Med J (Clin Res Ed) 1985 Mar 16;290(6471):815–819. doi: 10.1136/bmj.290.6471.815. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES